investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm
Andrew M Evens
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Non-Hodgkin lymphoma
Pathology
Ann M Moormann
Impact of Malaria on Shaping Immunity to EBV in the Etiology of Burkitt lymphoma
Non-Hodgkin lymphoma
Pathology
Jacqueline Barlow
Characterization of replication-mediated DNA damage in B lymphocytes
Non-Hodgkin lymphoma
Pathology
Eduardo Sotomayor
T-Cell Lymphoma Research, Research Radiology Collaborations
Non-Hodgkin lymphoma
Pathology
Nathanael S Gray
MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL
Non-Hodgkin lymphoma
Pathology
Roberto Chiarle
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
Non-Hodgkin lymphoma
Pathology
Louis Staudt
Oncogenic Mechanisms and Molecular Targets in Lymphoma
Non-Hodgkin lymphoma
Pathology
George Thomas
The Function of rpL5 and rpL11 in Induction of p53
Non-Hodgkin lymphoma
Pathology
John Nicholas
BH3-only Protein Targeting by HHV-8
Non-Hodgkin lymphoma
Pathology
